Asymmetric Total Synthesis of Cytotrienin A: Late-Stage Installation of C11 Side Chain onto the Macrolactam Scaffold

Angew Chem Int Ed Engl. 2023 Jul 17;62(29):e202303140. doi: 10.1002/anie.202303140. Epub 2023 Jun 12.

Abstract

Cytotrienin A, an ansamycin-class antibiotic, exhibits potent apoptosis-inducing activity and has attracted much attention as a lead compound for anticancer drugs. Herein, we report a new asymmetric synthetic route to cytotrienin A, employing an unexplored approach involving the late-stage installation of a C11 side chain onto the macrolactam core. In this strategy, we utilized the redox properties of hydroquinone and installed a side chain on the sterically hindered C11 hydroxy group by the traceless Staudinger reaction. This study also demonstrated that the boron-Wittig/iterative Suzuki-Miyaura cross-coupling sequence was effective for the concise and selective construction of the (E,E,E)-conjugated triene moiety. The developed route opens new opportunities for the structure-activity relationship studies of the side chains of these ansamycin antibiotics and the preparation of other synthetic analogs and chemical probes for further biological studies.

Keywords: Acylation; Cross-Coupling; Macrocycles; Redox Chemistry; Total Synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Lactams, Macrocyclic / pharmacology
  • Oxidation-Reduction
  • Rifamycins* / pharmacology
  • Structure-Activity Relationship

Substances

  • cytotrienin A
  • Lactams, Macrocyclic
  • Rifamycins